Incomplete resections (R1 or R2) are associated with a significantly higher risk of recurrence (Evans et al., 2021)
If you are curious about how GLP-1s impact women in particular, you can dive deeper on our sex-specific guide, to see unique considerations
Answer #3 I think at a high level, you should expect some degree of fluidity right over the next couple of years , just given I think theres going to be not only a changing market dynamic with the current medication that are on shortage
Despite high price tags, the Wegovy and Zepbound obesity drugs are considered to be cost effective, because they help patients lose substantial weight that, in turn, reduces the risk of high blood pressure and diabetes, among other ailments, according to a preliminary analysis
What are the next steps related to the FDA and peptides
Interest in GHK-Cu continues to grow because researchers are increasingly exploring